Capital International’s BioNTech BNTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-24,688
Closed -$1.98M 144
2024
Q2
$1.98M Buy
24,688
+1,814
+8% +$166K 0.09% 130
2024
Q1
$2.11M Buy
22,874
+1,808
+9% +$173K 0.1% 135
2023
Q4
$2.22M Buy
21,066
+216
+1% +$21.8K 0.11% 138
2023
Q3
$2.27M Sell
20,850
-267
-1% -$29.5K 0.13% 132
2023
Q2
$2.28M Buy
21,117
+2,603
+14% +$293K 0.13% 131
2023
Q1
$2.31M Buy
18,514
+867
+5% +$119K 0.14% 136
2022
Q4
$2.65M Buy
17,647
+1,593
+10% +$245K 0.18% 126
2022
Q3
$2.17M Buy
16,054
+13,578
+548% +$2.08M 0.15% 127
2022
Q2
$369K Sell
2,476
-15,393
-86% -$2.35M 0.03% 152
2022
Q1
$3.05M Buy
17,869
+2,651
+17% +$445K 0.17% 117
2021
Q4
$3.92M Buy
15,218
+4,268
+39% +$1.17M 0.2% 112
2021
Q3
$2.99M Sell
10,950
-4,947
-31% -$1.57M 0.16% 123
2021
Q2
$3.56M Buy
15,897
+5,559
+54% +$1.05M 0.2% 116
2021
Q1
$1.13M Buy
+10,338
New +$1.1M 0.07% 143

Other funds holding BNTX

Capital International's BNTX Position: Q3 2024 in Review

Capital International sold out of BioNTech (BNTX) in Q3 2024, closing a stake of 24,688 shares — an estimated $1.98M sold.

Capital International first reported a position in BNTX in Q1 2021 and held it in 14 quarters. The position peaked at $3.92M in Q4 2021. 296 funds tracked by Wall St. Rank hold BNTX as of Q3 2024.

  • Capital International reported no remaining BioNTech position as of Q3 2024 after selling out during the quarter.
  • Capital International sold 24,688 BioNTech shares in Q3 2024, an estimated $1.98M.
  • Capital International first reported a position in BioNTech in Q1 2021 and held it in 14 quarters.
  • Capital International's BioNTech position peaked at $3.92M in Q4 2021.
  • 296 funds tracked by Wall St. Rank held BioNTech as of Q3 2024.

Based on Capital International's 13F filing for Q3 2024, filed 13 Nov 2024.